Showing results (51-60 of 406) with videos related to
Sort By:
Pageof 41
Journal of Clinical Medicine|October 13, 2021
Distinct Effects of Interleukin-1β Inhibition upon Cytokine Profile in Patients with Adult-Onset Still's Disease and Active Articular Manifestation Responding to CanakinumabKhetam Ghannam, Jan Zernicke, Claudia Kedor, et al.Immunobiology|February 28, 2003
Casein is an essential cofactor in autoantibody reactivity directed against the C-terminal SmD1 peptide AA 83-119 in systemic lupus erythematosusGabriela Riemekasten, Jeannette Marell, Christian Hentschel, et al.Annals of the Rheumatic Diseases|May 8, 2012
Adalimumab: long-term safety in 23 458 patients from global clinical trials in rheumatoid arthritis, juvenile idiopathic arthritis, ankylosing spondylitis, psoriatic arthritis, psoriasis and Crohn's diseaseGerd R Burmester, Remo Panaccione, Kenneth B Gordon, et al.Arthritis Research & Therapy|April 25, 2006
Initial clinical trial of epratuzumab (humanized anti-CD22 antibody) for immunotherapy of systemic lupus erythematosusThomas Dörner, Joerg Kaufmann, William A Wegener, et al.Arthritis Research & Therapy|February 14, 2006
Detailed analysis of the variability of peptidylarginine deiminase type 4 in German patients with rheumatoid arthritis: a case-control studyBerthold Hoppe, Thomas Häupl, Rudolf Gruber, et al.Annals of the Rheumatic Diseases|December 29, 2010
Effectiveness and safety of the interleukin 6-receptor antagonist tocilizumab after 4 and 24 weeks in patients with active rheumatoid arthritis: the first phase IIIb real-life study (TAMARA)Gerd R Burmester, E Feist, H Kellner, et al.Rheumatology and Therapy|January 12, 2026
Rationale, Design and Methods of the Filgotinib Initial Response Study in Rheumatoid Arthritis (FIRST-RA)Georg Pongratz, Rieke Alten, Torsten Witte, et al.Rheumatology (Oxford, England)|March 19, 2021
Rituximab plus leflunomide in rheumatoid arthritis: a randomized, placebo-controlled, investigator-initiated clinical trial (AMARA study)Frank Behrens, Michaela Koehm, Tanja Rossmanith, et al.Deutsche Medizinische Wochenschrift (1946)|June 4, 2020
[Treatment strategies in psoriatic arthritis]Michaela Köhm, Harald Burkhardt, Frank BehrensClinical and Experimental Rheumatology|October 17, 2015
Anti-TNFα-therapy as an evidence-based treatment option for different clinical manifestations of psoriatic arthritisMichaela Köhm, Harald Burkhardt, Frank BehrensPageof 41